Lentiviral Vector Resource
Lentiviral vector plasmids combine a transfer backbone, transgene expression elements, selection markers, and packaging signals to enable stable and efficient gene delivery. Selecting the appropriate plasmid backbone and second- or third-generation packaging system is essential for balancing expression, biosafety, viral titer, and application-specific performance. Choosing the right backbone—from classic pLKO.1, pLenti-CMV, and pLVX-Puro to third-generation pCDH—and matching it to the correct vector design and packaging system determines titer, expression stability, and safety.
Direct Answer
A plasmid map describes the DNA sequence landmarks that determine how a vector replicates, is selected, and expresses its cargo. Understanding these elements is the first step to choosing the right backbone.
For lentiviral vector development, the transfer plasmid must additionally carry cis-acting signals—LTRs, packaging signal (Ψ), and RRE—that let the vector RNA be recognized, packaged, and reverse-transcribed.
The key principle: a good backbone balances a strong, appropriate promoter with the smallest necessary marker set, because every added element consumes packaging capacity.
The origin of replication determines the host and plasmid copy number during bacterial amplification before packaging.
Bacterial markers (Amp/Kan) select transformed colonies; eukaryotic markers (Puro/Blasticidin/Neo/Hygro) select transduced cells.
A cluster of unique restriction sites where the gene of interest is cloned downstream of the promoter.
Promoters, enhancers, Kozak sequence, and polyadenylation or termination signals drive and tune transgene expression.
Backbone Comparison
Different backbones are optimized for different purposes—RNAi, overexpression, selection, or dual-promoter control. The choice should follow the experiment, not habit.
| Backbone | Promoter / Marker | Best Use | Key Feature |
|---|---|---|---|
| pLKO.1 | U6-driven shRNA, PGK-puromycin (standard pLKO.1) | Gene knockdown, RNAi | Established shRNA knockdown backbone; variants differ |
| pLenti-CMV-GFP | CMV, EGFP | High-level protein expression | Fast fluorescent selection of transduced cells |
| pLVX-Puro | CMV, Puro | Protein and RNAi expression | Drug selection for stable pools |
| pCDH | Dual promoter (CMV + EF1) | Co-expression of gene and reporter | Third-generation, dual-promoter control |
For silencing applications, see lentiviral vector design for gene silencing and custom shRNA lentivirus service. For multi-gene constructs, explore bicistronic lentiviral vector optimization.
Packaging Systems
Lentiviral particles are produced by co-transfecting the transfer plasmid with packaging plasmids in HEK293T cells. The generation of the system defines how viral components are split across plasmids—and therefore how safe and tunable the system is.
Transfer plasmid + packaging plasmid (psPAX2, encoding gag/pol/rev) + envelope plasmid (pMD2.G, VSV-G). Widely used and well characterized.
Transfer plasmid + pLP1 (gag/pol) + pLP2 (rev) + pLP/VSVG. Rev is split onto its own plasmid and tat is removed, further reducing the risk of replication-competent virus.
Vector Elements
The functional behavior of a lentiviral vector is set by its regulatory elements. These choices determine expression level, cell specificity, and how easily you can select or visualize transduced cells.
Broad promoters (CMV, CAG, EF1α, PGK) for general expression; U6/H1 for shRNA and sgRNA; tissue-specific promoters for cell-type-restricted expression.
eGFP, ZsGreen1, mCherry, and mScarlet enable infection monitoring and FACS enrichment of positive cells.
Puro and Blasticidin are the most common eukaryotic markers for stable cell-line selection; Neo, Hygro, and Zeo offer alternatives.
3xFLAG, 6xHis, HA, Myc, and GST enable detection, purification, and subcellular localization studies.
2A peptides are compact and give balanced co-expression; IRES allows independent translation but is larger and weaker downstream.
Tet-on/off and other inducible systems add temporal control for dose-dependent or toxic transgenes.
Decision Framework
Match the backbone to the assay and the packaging generation to the safety and titer requirements of your model.
Choose pLKO.1-style vectors: a U6-driven shRNA and a selectable marker for stable knockdown; confirm the exact marker and cassette in the chosen variant.
Choose pLenti-CMV or pLVX-Puro: strong CMV-driven expression with GFP or drug selection.
Choose pCDH: dual-promoter design for independent control of transgene and marker.
Choose third-generation packaging: split rev and tat removal minimize replication-competent virus risk.
Pre-Packaging Review
A generation label alone cannot establish whether a transfer plasmid and helper set work together. Review the specific maps and the intended readout before committing to production.
Confirm the 5′ LTR design and whether transfer-vector transcription requires Tat. A Tat-independent third-generation transfer vector can often be packaged with compatible second- or third-generation helpers; a Tat-dependent second-generation transfer vector needs a system that supplies Tat.
Locate the packaging signal, insert, promoter, marker, and LTRs on the transfer-vector map, and distinguish the intended packaged region from bacterial backbone sequences. Confirm sequence identity and consider how the total vector genome length may affect yield.
Specify whether success means reporter positivity, transgene expression, knockdown, or stable selection. Choose an assay that measures the relevant function in a suitable cell model; a physical particle measurement alone does not establish functional titer in the target cells.
Record the packaging configuration, envelope, titer method, and lot-specific quality results. Plan controls and any replication-competent lentivirus testing according to the study context and applicable institutional requirements.
From Question to Evidence
Creative Biolabs can design, construct, optimize, and package your lentiviral vector plasmid into high-titer particles, ready for transduction and stable cell-line generation.
Select a backbone that fits the insert, expression goal, and downstream readout. The design review can align promoter, selectable or fluorescent marker, and any tag with the target cell model, then confirm the insert sequence and junctions on a documented plasmid map before packaging.
Evaluate whether the current construct's promoter, coding sequence, and regulatory elements support the desired expression profile. Where appropriate, sequence optimization and element changes can be assessed alongside genome length, transcript integrity, and target-cell performance; improvements in expression or particle yield are verified rather than assumed.
Match the transfer vector to a compatible second- or third-generation helper set and a suitable envelope for the intended model. Production planning can include lot scale, concentration, and characterization, with the reported titer and handling conditions supplied for the resulting material rather than inferred from the plasmid design.
Measure infectious or functional titer with an assay suited to the vector and its readout, and document the cell line and method used. Because physical particle counts and functional units describe different attributes, the assay basis should accompany any MOI calculation and comparisons across lots or target cells.
Browse existing recombinant lentivirus products when a standard target or reporter meets the experiment's needs. Check the specific construct, promoter, marker, envelope, and available lot information against the study design before substituting a catalog product for a custom vector.
Selected Reading
Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, Naldini L. A third-generation lentivirus vector with a conditional packaging system. J Virol. 1998;72(11):8463-8471. https://doi.org/10.1128/JVI.72.11.8463-8471.1998.
Naldini L, Blömer U, Gallay P, et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science. 1996;272(5259):263-267. https://doi.org/10.1126/science.272.5259.263.
Cronin J, Zhang XY, Reiser J. Altering the tropism of lentiviral vectors through pseudotyping. Curr Gene Ther. 2005;5(4):387-398. https://doi.org/10.2174/1566523054546224.
FAQ
Tell us about your project, and our experts will get back to you with a customized quote and proposal.
